FDA Inspection
Piramal Pharma LimitedPiramal Pharma Limited – FDA Inspection, Aug 30, 2019
Record Details
This FDA Inspection record concerns Piramal Pharma Limited, with an inspection on August 30, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Person
- Angela E. Glenn (Issuing Officer)
View Company Profile
ID · 86b06f35-28c9-4f71-bae0-6fefd203f2c6
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1103288
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Piramal Pharma Limited
8| Date | Classification | Office | Project area |
|---|---|---|---|
| May 19, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 18, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 21, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 30, 2015 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
| April 3, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Piramal Pharma Limited
- FDA Inspection 1208559 - 2023-05-19
- FDA Inspection 1081925 - 2019-01-18
- FDA Inspection 1005197 - 2017-02-21
- FDA Inspection 951067 - 2015-10-30
- FDA Inspection 924411 - 2015-04-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.